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                         Abstract 
Background :  To evaluate the prevalence of beta 
thalassemia trait (BTT) among the students of 
schools, colleges and universities of Nawabshah city. 
  
Methods:  In this descriptive cross sectional study 
students of schools, colleges and universities of 
Nawabshah were selected. The blood samples from 
these subjects were tested for complete blood count, 
 and red cell indices. The microscopic examination of 
peripheral blood smears stained with Field’s stain 
was performed for the morphology of red blood 
cells. Serum ferritin  and  automated haemoglobin 
electrophoresis at cellulose acetate alkaline pH was 
performed. Subjects with microcytic hypochromic 
blood picture and low ferritin level were not 
subjected to haemoglobin electrophoresis.  
Results: In total of 521 subjects 65.4% were females, 
with female to male ratio of 1.8:1. Mean age was 17.5 
years. On screening diagnosis of beta thalassemia 
trait was made in 4.9% cases and haemoglobin 
electrophoresis showed mean haemoglobin A2 of 
5.8% in these cases. The microscopic examinations of 
peripheral blood smears among the subjects with 
BTT showed microcytic hypochromic red blood cells 
with presence of target cells.   
Conclusion: The prevalence of beta thalassemia 
BTT was 4.9%.   
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Introduction 
       Thalassaemia was first discovered in a child with 
severe anaemia, splenomegaly and characteristic bone 
changes. The name was originated from the Greek 
word thalassa (sea) and mias (blood), as  its prevalence 
was more commonly observed in people of 
Mediterranean countries.1 Thalassaemias which are 
inherited autosomal recessive disorder are divided 
into alpha and beta thalassaemias, the former results 
from deletion of alpha gene located on chromosome 16 
while Beta thalassaemias is caused by genetic defect 
like mutation on the chromosome 11, leading to either 
complete absence or decreased synthesis of beta 
chain.2 The beta thalassemia is divided into the beta 
thalassemia major and beta thalassaemia minor. 
Clinical features of beta thalassaemia major includes 
severe type of haemolytic anaemia appearing at 06 
month of age when fetal haemoglobin changes into the 
adult haemoglobin, hepatosplenomegaly and mongol 
like face due to the bone changes. Estimation of 
haemoglobin red blood cell indices, peripheral blood 
smear reveals microcytic hypochromic anaemia 
usually with nucleated red blood cells and 
haemoglobin electrophoresis reveals decrease 
haemoglobin A with variable increase in haemoglobin 
F. The patients with beta thalassemia minor are 
asymptomatic and may be diagnosed because of 
presence of microcytic hypochromic red blood cells 
with mild anaemia. Haemoglobin electrophoresis in 
these patients reveals an increased haemoglobin A2 
level.4 To differentiate the types of microcytic 
hypochromic anemia such as iron deficiency anemia 
and beta thalassemia trait, the hemoglobin 
concentration, RBC count and mean corpuscular 
volume estimation are useful laboratory tests.5  For 
any CBC showing low hemoglobin, MCV <75,MCH 
<25 and RBC count > 5.0 millions/cmm. Hb 
Electrophoresis at alkaline pH should be done after 
excluding iron deficiency. An elevated HbA2 is 
diagnostic of β-thalassaemia trait. For normal HbA2 
level with low MCV & MCH, consider alternative 
diagnosis viz. iron deficiency anaemia and α-
thalassaemia trait. .6-9 In Pakistan, overall life 
expectancy of thalassaemic children is around 10 to 12 
years. For proper management of a thalassaemic child 
which include enough and safe blood supply and best 
iron chelation therapy along with other medical and 
psychosocial management the total expenditure on the 
management of thalassaemic children throughout the 
country is enormously high and most of the children in 
Pakistan suffering from thalassaemia are getting sub 
optimal treatment.  Thus the prevention of beta 
thalassemia major is more important aspect of disease 
management. Screening to identify carriers, genetic 
counselling, and prenatal diagnosis (done by analysis 
of DNA of chorionic villous sampling in 10-12 weeks 
of pregnancy) can greatly reduce the rate of birth of 
affected infants and improve the prognosis of affected 
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patients. Different approaches have been observed 
throughout the world for screening of thalassaemia. 
Screening families of index child with thalassaemia 
has shown promising results. Screening can be done 
for those who are candidates for marriage, or in 
schools, colleges or at prenatal clinics. 6-8 
 
Subjects and Methods 
     This cross sectional descriptive study was 
conducted at Pathology Department of PUMHS In 
total 521 students of schools, colleges & universities of 
Nawabshah city were included in the study. The 
awareness regarding the thalassemia was created by 
distributing pamphlets to the each student and 
detailed history including information regarding 
history of any family member with beta thalassemia 
major was filled. The blood samples from these cases 
were taken for the diagnosis of beta thalassaemia trait. 
Complete blood counts including haematological 
parameters such as haemoglobin g/dl, red cell indices 
(PCV, MCV, MCH & MCHC) were performed . The 
microscopic examination of peripheral blood smear 
stained with Field’s stain was performed for the 
morphology of RBC. Serum ferritin concentration was 
tested by solid phase Automated Enzyme linked 
Immunoassay. Cases with microcytic hypochromic 
anaemia and low ferritin levels were excluded. Cases 
of microcytic hypochromic picture were evaluated for 
beta thalassemia trait on automated haemoglobin 
electrophoresis at cellulose acetate alkaline pH. 
Hemoglobin A2 was analyzed by micro column 
technique .  
 
Results 
     Total 521 subjects were screened for BTT including 
65.4% females, with female to male ratio of 1.8:1. Mean 
age of these subjects was 17.5 years (Table 1). The 
mean values of haemoglobin g/dl, RBC count 
millions/cmm, PCV %, MCV fl, MCH pg, MCHC 
g/dl, TLC count /cmm, and platelet count /cmm 
among these subjects were 11.9 g/dl, 4.5 
millions/cmm, 82 fl, 38.7%, 26.9 pg, 33.2 g/dl, 
8000/cmm and 310,000/cmm  respectively. Serum 
Ferritin level <15ug/dl was taken as cut off for IDA. 
Peripheral blood smear morphology revealed 
hypochromic microcytic red cell picture with presence 
of target cells in BTT positive case. On Hb 
Electrophoresis the mean HbA2 in cases was 5.8% and 
HbF was 0.7. Out of total 521 subjects, 26 subjects were 
found to be BTT therefore prevalence of BTT was 
found out to be 4.9% in this group (Table 2). 
Table 1: Demographic and laboratory 
parameters of  screened subjects  
Characteristics  Total Subjects (n=521) 
Mean age 17.5 years 
Sex  
Female % 
Male % 
 
341 (65.4%) 
180 (34.6%) 
Female to male ratio 1.8:1 
Laboratory parameters 
Hemoglobin g/dl  
PCV %  
MCV fl  
MCH  pg 
MCHC g/dl  
RBC count million/cmm 
TLC /cmm 
Platelet count /cmm  
Serum ferritin ug/dl 
 
11.8 g/dl 
38.7% 
82fl 
26.9pg 
33.2g/dl 
4.5 million/cmm 
8000/cmm 
310,000/cmm 
15 ug/dl 
 
Table 2: Laboratory Parameters in BTT Subjects  
Laboratory parameters BTT(n=26) 
RBC mil/cumm (Mean+SD) 5.1 + 1.1 
MCV fl (Mean+SD) 72.8 + 5.4 
MCH pg/dl (Mean+SD) 19.9 + 2.5 
MCHC g/dl (Mean+SD) 31.2 + 1.2 
RDW %  (Mean+SD) 13.9 + 2.4 
Serum Ferritin ug/dl (Mean+SD) 15.4 + 0.7 
Hemoglobin A2 level % (Mean+SD) 5.8 + 0.8  
 
Discussion 
    Beta Thalassemia is a genetically transmitted blood 
disorder with a carrier rate of 5-8% and around 5000 
children are diagnosed, with beta thalassaemia major, 
each year, in Pakistan.9 Carriers of beta thalassaemia 
are usually symptomless. Haemoglobin is usually 
between 10-12 gm/dl.  These people do not require 
blood transfusion. Its diagnosis is based on the finding 
of raised Hb A2, i.e. between 3.5- 7.0% (normal 1.5-
3.0%) on haemoglobin electrophoresis. Concomitant 
iron deficiency and silent mutations can be 
confounding in haemoglobin electrophoresis for 
thalassaemia trait. In such situations molecular studies 
are imperative.9  
     World over, the carrier rate of BTT  varies from 1.7 
to 9 %. Approximately, 60,000 children are born with 
beta thalassaemia major, annually. In Pakistan carrier 
rate varies from 1 to 7 per cent. Each year 5000 
children are born with beta thalassaemia major.10-17  
Screening for thalassaemia trait can dramatically  
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decrease the incidence of thalassaemia major births by 
the premarital screening and genetic counselling, as in 
Saudi Arabia with 3.4 prevalence rate reported by 
Ziad Ahmed M and Mohammad Y.S. 18 In Iran 
premarital screening of beta thalassemia was carried 
out by estimation of hemoglobin concentration, red 
cell indices, microscopic examination of peripheral 
blood smear, hemoglobin electrophoresis and genetic 
counseling of both partners as reported by Karimi M et 
al.19The cases of beta thalassemia major reduced or 
even eradicated some countries Cyprus, Greece and 
Italy by the process of prenatal diagnosis of 
thalassemia during pregnancy with abortion of child 
as reported by Leung TN et al.20  Our study of 
prevalence of BTT is comparable with local study in 
Pakistan and international study in Bangladesh, India, 
Srilanka, China and Turkey  while detection of BTT by 
hematological parameters were confirmed by local 
study in Pakistan 17 and international study in 
Iran.13,17,19,21 
    There are several countries in the world where 
premarital thalassaemia screening is mandatory as 
described in this context but our situation is different 
due to the faith, religious facts, illiteracy  and 
increased consanguinity. A thalassaemia prevention 
bill was moved in Sindh assembly but the 
implementation is still pending. Globally, efforts have  
been made for prevention of thalassaemias by mass 
education and various prevention strategies like, mass 
screening, extended family screening of the index 
child, prenatal diagnosis and termination of pregnancy 
and pre-marital screening. The prenatal diagnosis and 
termination of pregnancy is not uniformly practised in 
all religions and societies, although increased trend is 
seen in modern societies and part of the world with 
high literacy rate. For a successful prevention 
program, support from all stakeholders including 
religious scholars, electronic and print media, 
gynaecologists, paediatricians, thalassaemic  families, 
government and non government organizations is 
required. 
 
Conclusion 
1.Thalassaemia is the most common genetic disorder 
in our set up.  
2.Screening programs are required at the national level 
to reduce further burden of beta thalassemia major 
births in our community.  
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